Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+7.47%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$56.6B
AUM Growth
+$2.63B
(+4.9%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
29.54%
Holding
970
New
110
Increased
283
Reduced
395
Closed
105
Top Buys
| 1 |
HES
Hess
HES
|
$285M |
| 2 |
3M
MMM
|
$208M |
| 3 |
Bristol-Myers Squibb
BMY
|
$187M |
| 4 |
Dover
DOV
|
$150M |
| 5 |
Waste Management
WM
|
$145M |
Top Sells
| 1 |
CSX Corp
CSX
|
$201M |
| 2 |
Merck
MRK
|
$191M |
| 3 |
Deere & Co
DE
|
$122M |
| 4 |
RB Global
RBA
|
$108M |
| 5 |
ConocoPhillips
COP
|
$106M |
Sector Composition
| 1 | Technology | 28.49% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 10.57% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
726
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $4.45M | 0.01% |
2,071,914
| – | – |
|
727
Owens Corning
OC
$12.7B
| $4.41M | 0.01% |
25,000
-85,000
| -77% | -$15M |
|
728
Shift4
FOUR
$6.01B
| $4.34M | 0.01% |
+49,000
| New | +$4.34M |
|
729
MidWestOne Financial Group
MOFG
$625M
| $4.28M | 0.01% |
+150,000
| New | +$4.28M |
|
730
Werewolf Therapeutics
HOWL
$61.7M
| $4.24M | 0.01% |
2,000,594
| – | – |
|
731
NET Power
NPWR
$174M
| $4.21M | 0.01% |
600,000
-73,350
| -11% | -$514K |
|
732
Equitable Holdings
EQH
$16.2B
| $4.2M | 0.01% |
100,000
-30,000
| -23% | -$1.26M |
|
733
DTE Energy
DTE
$28.3B
| $4.19M | 0.01% |
32,612
-165,900
| -84% | -$21.3M |
|
734
Apple Hospitality REIT
APLE
$3.09B
| $4.08M | 0.01% |
275,000
-225,000
| -45% | -$3.34M |
|
|
LAC
735
Lithium Americas
LAC
$674M
| $4.05M | 0.01% |
1,500,000
| – | – |
|
736
Seagate
STX
$39.1B
| $3.99M | 0.01% |
+36,401
| New | +$3.99M |
|
737
Global E Online
GLBE
$5.95B
| $3.84M | 0.01% |
+100,000
| New | +$3.84M |
|
|
CTNM
738
Contineum Therapeutics
CTNM
$308M
| $3.83M | 0.01% |
200,000
-95,000
| -32% | -$1.82M |
|
739
Ally Financial
ALLY
$12.8B
| $3.81M | 0.01% |
+107,171
| New | +$3.81M |
|
|
AMTM
740
Amentum Holdings, Inc.
AMTM
$5.88B
| $3.81M | 0.01% |
+118,027
| New | +$3.81M |
|
741
Assurant
AIZ
$10.9B
| $3.75M | 0.01% |
18,840
-11,000
| -37% | -$2.19M |
|
742
Knight Transportation
KNX
$7.16B
| $3.66M | 0.01% |
67,755
-36,918
| -35% | -$1.99M |
|
743
Karyopharm Therapeutics
KPTI
$58.4M
| $3.59M | 0.01% |
287,989
| – | – |
|
744
CytomX Therapeutics
CTMX
$346M
| $3.54M | 0.01% |
3,000,000
| – | – |
|
745
Kimbell Royalty Partners
KRP
$1.28B
| $3.54M | 0.01% |
220,000
+20,000
| +10% | +$322K |
|
746
Match Group
MTCH
$9B
| $3.52M | 0.01% |
93,116
-11,700
| -11% | -$443K |
|
|
CNR
747
Core Natural Resources, Inc.
CNR
$3.64B
| $3.35M | 0.01% |
+32,000
| New | +$3.35M |
|
748
Immunome
IMNM
$853M
| $3.22M | 0.01% |
220,000
| – | – |
|
749
Carnival Corp
CCL
$43.1B
| $3.17M | 0.01% |
171,700
+28,800
| +20% | +$532K |
|
|
RGLS
750
DELISTED
Regulus Therapeutics
RGLS
| $3.14M | 0.01% |
2,000,000
| – | – |
|